Yazar "Yazgan, Serkan" seçeneğine göre listele
Listeleniyor 1 - 8 / 8
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Chest wall resection for lung cancer: A 12-year experience in a single center(European Respiratory Soc Journals Ltd, 2021) Üçvet, Ahmet; Batıhan, Güntug; Yazgan, Serkan; Ceylan, Kenan Can; Gürsoy, Soner; Kaya, Şeyda Örs[Abstract Not Available]Öğe Concomitant Chest Wall Resection and Reconstruction in a Cohort of 254 Patients of Non-small Cell Lung Cancer Resections Between 2007 and 2019: a 12-Year Experience from a Single Center in Turkey(Springer India, 2023) Batihan, Guntug; Ucvet, Ahmet; Yazgan, Serkan; Ceylan, Kenan Can; Gursoy, Soner; Kaya, Seyda OrsLung cancer with chest wall invasion, which constitute 5-10% of operable non-small cell lung cancer cases, is heterogeneous in terms of factors that may affect the prognosis. We aim to share our experience including the surgical results of patients with non-small cell lung cancer (NSCLC) who underwent chest wall resection and identify the potential factors that may impact survival. The patients who underwent combined chest wall and lung resection due to primary lung cancer invading the chest wall in our center between 2007 and 2019 were reviewed. Variables such as age, tumor size, histological subtype, surgical technique, depth of invasion, the extent of resection, neoadjuvant, and adjuvant treatment status were examined. Two hundred fifty-four patients who underwent combined chest wall and lung resection were included in the study. There were 245 men and 9 women. The mean age was 61.0 SD8.4 years. The overall survival was 70.9 SD4.6 months, and the 5-year survival rate was 41.5 SD3.3%. In multivariate analyses, age, the extent of lung resection, the number of resected ribs, invasion depth, and completeness of chest wall resection were independent factors that have an effect on survival. This study shows that age, the extent of lung and chest wall resection, invasion depth, and completeness of chest wall resection are independent prognostic factors of survival in patients who underwent combined lung and chest wall resection for NSCLC. Institutional Review Board of the Dr Suat Seren Chest Diseases and Surgery Medical Practice and Research Center (No: E-49109414-604.02.02).Öğe The impact of dissection of station 9 on survival and the necessity of pulmonary ligament division during upper lobectomy for lung cancer(Taylor & Francis Ltd, 2021) Yazgan, Serkan; Ücvet, Ahmet; Türk, Yunus; Gürsoy, SonerBackground We conducted this study to investigate the need for dissection of station 9 lymph nodes during upper lobectomy for non-small-cell lung cancer (NSCLC) and to find out the operative results of inferior pulmonary ligament division. Methods A total of 840 patients who underwent upper lobectomy for NSCLC between January 2007 and June 2020 were evaluated retrospectively. The patients were separated into two groups - those having undergone lymph node dissection of station 9 and inferior pulmonary ligament dissection (Group I) and those who did not (Group II). In these groups, the prognostic value of station 9 lymph nodes and postoperative effects (drainage time, prolonged air leak, dead space and length of hospital stay) of ligament division or preservation were analyzed. Results The number of patients with station 9 lymph node metastasis was only one (0.1%) and that was multi-station pN2 disease. Station 9 lymph nodes were found in 675 (80.4%) patients, while 22 (2.6%) patients had no lymph nodes in the dissected material. In the other 143 (17%) patients, the inferior pulmonary ligament and station 9 were not dissected. While 5-year survival was 64.9% in 697 patients of Group I, it was 61.3% in 143 patients of Group II (p = 0.56). There was no statistically significant difference between the groups in postoperative effects of ligament division or preservation. Conclusions In upper lobectomies, status of station 9 does not have a significant impact on patients' survival and lymph node staging. Additionally, preservation or division of the inferior pulmonary ligament has no significant advantage or disadvantage.Öğe Iterative surgical resections in non-small cell lung cancer(Termedia Publishing House Ltd, 2021) Üçvet, Ahmet; Yazgan, Serkan; Samancılar, Özgür; Gürsoy, Soner; Erbaycu, Ahmet Emin; Kömürcüoğlu, BernaIntroduction: We reviewed our surgical preferences and the prognosis for recurrent and second primary tumors in patients who underwent surgical treatment for non-small cell lung carcinoma (NSCLC). Aim: We report our experience with patients undergoing iterative pulmonary resection for lung cancer. Material and methods: Among patients who underwent anatomical resection for primary NSCLC, those who underwent a second surgical resection between 2010 and 2020 due to recurrent or second primary tumor were included in the study. Operative mortality, survival, and prognostic factors were investigated. Results: In total, 77 cases were included: 31 (40.3%) underwent the second resection for the recurrent disease and 46 (59.7%) underwent the second resection for the second primary tumor. Postoperative mortality occurred in 8 (10.4%) patients. All patients with postoperative mortality were in the group that underwent thoracotomy in both surgical procedures. The 5-year survival rate was 46.5%. The 5-year survival of those operated on for recurrent or second primary tumor was 32.8% and 51.1%, respectively (p = 0.81). The 5-year survival rate was 68.8% in patients under the age of 60 years, while it was 27.5% in patients aged 60 years and above (p = 0.004). The 5-year survival was 21.8% in patients with an interval of 36 months or less between two operations and 72.2% in those with a longer interval (p = 0.028). Conclusions: Our study shows that survival results similar to or better than primary NSCLC surgery can be obtained with lower mortality if more limited resections are performed via video-assisted thoracic surgery, especially in young patients. In addition, the prognosis is better in patients with an interval of more than 36 months between two operations.Öğe Iterative surgical resections in non-small cell lung carcinoma(European Respiratory Soc Journals Ltd, 2021) Üçvet, Ahmet; Yazgan, Serkan; Samancılar, Özgür; Gürsoy, Soner; Erbaycu, Ahmet Emin; Kömürcüoğlu, Berna[Abstract Not Available]Öğe Pleural complications and chest tube follow-up in patients with COVID-19(European Respiratory Soc Journals Ltd, 2021) Ceylan, Kenan Can; Batıhan, Güntuğ; Yazgan, Serkan; Gürsoy, Soner; Kıraklı, Sami Cenk; Ataman, SenaIntroduction: It was reported that the SARS-CoV-2 virus primarily affects the lower respiratory system and various pleural complications may accompany coronavirus disease 2019 (COVID-19). Aims and objectives: We aimed to present the characteristics of patients who underwent a chest tube insertion due to pleural complications during COVID-19 disease and the technique we developed to minimize possible contamination from the underwater seal bottle in these patients. Methods: We retrospectively examined the characteristics of patients who developed pleural complications during COVID-19 disease in our hospital between March 11 and May 15, 2020. Results: Between March 11 and May 15, 2020, a total of 342 patients were hospitalized with the diagnosis of COVID-19. Tube thoracostomy was performed in 13 (%3.8) of these patients due to pleural complications. Indications for chest tube placement were: Pneumothorax in six (%46.1) patients, pleural effusion in three (%23) patients, empyema in three (%23) patients, and hemothorax in one patient (%7.6). A high-efficiency particulate air (HEPA) viral filter mounted two bottle technique was used in the follow-up of chest drainsÖğe Surgical and survival outcomes of sleeve lobectomy after neoadjuvant theraphy in lung cancer: With group of 265 patients(European Respiratory Soc Journals Ltd, 2021) Ceylan, Kenan Can; Üçvet, Ahmet; Arabacı, Bengisu; Yazgan, Serkan; Gürsoy, Soner[Abstract Not Available]Öğe Video-assisted thoracoscopic lobectomy and bilobectomy versus open thoracotomy for non-small cell lung cancer: Mortality and survival(Baycinar Medical Publ-Baycinar Tibbi Yayincilik, 2022) Üçvet, Ahmet; Yazgan, Serkan; Samancılar, Özgür; Türk, Yunus; Gürsoy, Soner; Erbaycu, Ahmet EminBackground: In this study, we aimed to evaluate patients who had non-small cell lung cancer and underwent resection, to investigate our tendency to prefer video-assisted thoracic surgery or open thoracotomy, and to compare 30-and 90-day mortalities and survival rates. Methods: Between January 2013 and January 2019, a total of 706 patients (577 males, 129 females; mean age: 61.9 +/- 8.6 years; range, 17 to 84 years) who underwent lobectomy or bilobectomy due to primary non-small cell lung cancer were retrospectively analyzed. The patients were divided into two groups as operated on through video-assisted thoracic surgery and through open thoracotomy. The 30-and 90-day mortality rates and survival rates were compared. Results: Of the patients, 202 (28.6%) underwent video-assisted thoracic surgery and 504 (71.4%) underwent open thoracotomy. Lobectomy was performed in 632 patients (89.5%) and bilobectomy was performed in 74 patients (10.5%). Patients who were chosen for video-assisted thoracic surgery were statistically significantly older, did not require any procedure other than lobectomy, did not receive neoadjuvant therapy, had a small tumor, and did not have lymph node metastases. The 30-and 90-day mortality rates in the video-assisted thoracic surgery and open thoracotomy groups were 1.8% vs. 2% and 2.6% vs. 2.5%, respectively. The five-year survival rates of video-assisted thoracic surgery and open thoracotomy groups were 74.1% and 65.2%, respectively (p>0.05). The 30-and 90-day mortality and five-year survival rates were 2.1%, 2.6%, and 73.5% in the video-assisted thoracic surgery group and 2.1%, 2.1%, and 68.5% in the open thoracotomy group, respectively, indicating no statistically significant difference between the two groups. Conclusion: Throughout the study period, video-assisted thoracic surgery was more preferred in patients with advanced age, in those who had a small tumor, who did not receive neoadjuvant therapy, did not have lymph node metastasis, and did not require any procedure other than lobectomy. In the video-assisted thoracic surgery and open thoracotomy groups, 30-and 90-day mortality and five-year survival rates were similar. Based on these findings, both procedures seem to be acceptable in this patient population.
